Highmark Client Tip Sheet CAA Section 204 Reporting 2026 December 2025 Updates: Highmark Pharmacy Blast: Pharmacy Program Updates and Reminders GLP-1 Coverage Update: Enhanced anti-obesity policy now includes coverage for members with BMI 40 and high-risk conditions (sleep apnea, cardiovascular disease, or advanced MASH), reflecting expanded clinical evidence
Your dose delivery will take around 45-minutes to complete
Regulatory status (as of April 2026) Retatrutide is not FDA approved and not EMA approved as of April 2026
For GLP-1 patients with potentially suppressed fibroblast support, this provides direct receptor-level stimulation through a pathway independent of the GLP-1 receptor
If you have questions about bariatric surgery in Arkansas and think you might be a candidate, reach out to us today to book your initial consultation with our caring, knowledgeable team.
Josef Hospital/Ruhr University Bochum, Germany, for helpful discussions